Literature DB >> 3162396

Cytogenetic, clinical, and cytologic characteristics of radiotherapy-related leukemias.

P Philip1, J Pedersen-Bjergaard.   

Abstract

From 1978 to 1985, we observed eight cases of acute nonlymphocytic leukemia or preleukemia, three cases of acute lymphoblastic leukemia, and three cases of chronic myeloid leukemia in patients previously treated exclusively with radiotherapy for other tumor types. The latent period from administration of radiotherapy to development of leukemia varied between 12 and 243 months. Clonal chromosome aberrations reported previously as characteristic of acute nonlymphocytic leukemia following therapy with alkylating agents were observed in three of the eight patients with acute nonlymphocytic leukemia (5q- and -7) and in two of the three patients with acute lymphoblastic leukemia (-7 and 12p-). All three patients with radiotherapy-related chronic myeloid leukemia presented a t(9;22)(q34;q11). The results suggest that cytogenetic characteristics may reflect the etiology in radiation-induced acute leukemias, whereas radiation-related chronic myeloid leukemia does not seem to differ chromosomally from de novo cases of the disease.

Entities:  

Mesh:

Year:  1988        PMID: 3162396     DOI: 10.1016/0165-4608(88)90221-x

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  3 in total

Review 1.  Therapy-related myeloid neoplasms: pathobiology and clinical characteristics.

Authors:  H Sill; W Olipitz; A Zebisch; E Schulz; A Wölfler
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

2.  Chronic myelogenous leukemia following radiation therapy for testicular seminoma.

Authors:  A Iurlo; P Foa; A T Maiolo; E E Polli
Journal:  Blut       Date:  1989-12

3.  Acute myeloid leukemia and myelodysplastic syndromes after radiation therapy are similar to de novo disease and differ from other therapy-related myeloid neoplasms.

Authors:  Valentina Nardi; Karen M Winkfield; Chi Young Ok; Andrzej Niemierko; Michael J Kluk; Eyal C Attar; Guillermo Garcia-Manero; Sa A Wang; Robert P Hasserjian
Journal:  J Clin Oncol       Date:  2012-05-14       Impact factor: 44.544

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.